high-risk HPV types only. MeSH Perkins RB, Guido RS, Castle PE, et al. 18 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. Michael Gold, MD; Robert Goulart, MD; Richard Guido, MD; Paul Han, MD; Sally Hersh, DNP; Aimee Holland, DNP; Eric Confirm your email to receive complimentary access to the ASCCP Management Guidelines web application. Therefore, incorporating HPV testing into risk stratification and recommendations for surveillance following abnormal results was an important part of the 2019 guidelines. Lower Anogenital Squamous Terminology (LAST): this term refers to two-tiered pathology criteria for The following clarifications specify management for additional scenarios. As of April 2021, the cost for the mobile app is $10. 1 0 obj
117 0 obj
<>/Filter/FlateDecode/ID[<2A3A72E8287AD77BE571CDCCA6D1568C><7C4167790C383844A9780EF022A9F20A>]/Index[104 29]/Info 103 0 R/Length 73/Prev 24323/Root 105 0 R/Size 133/Type/XRef/W[1 2 1]>>stream
Class 2A carcinogen (i.e., HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). Risk factors for HPV infection include early sexual contact, having multiple sex partners, a history of other sexually transmitted infections, HIV infection, an immunocompromised state, and not using barrier protection during sex.3,13,14, Persistent oral and genital HPV infections are associated with alcohol use and smoking.15,16 There is some evidence that human leukocyte antigen type may impact an individual's ability to clear HPV viruses.17 Although several factors have been associated with an increased risk of progression to cervical disease (e.g., age, body mass index, income, oral contraceptive use, race/ethnicity, smoking), persistent high-risk HPV infection is the most significant risk factor for progression.18,19, Infection with a low-risk HPV type does not preclude infection with a concomitant high-risk type. Please enable scripts and reload this page. has advised companies and participated in educational activities but does not receive any honoraria or payments for these activities, In some cases, his employer, Rutgers, receives payment for his time for these activities from Papivax, Cynvec, Merck, Hologic, and PDS Biotechnologies. -, Egemen D, Cheung LC, Chen X, et al. Furthermore, since prior test results affect risk, patients with prior abnormalities often require surveillance with evaluating histologic specimens obtained via colposcopic biopsy. However, the American Society for Clinical Pathology (ASCP) remains concerned about several other issues, summarized . patient's risk of progressing to precancer or cancer. 2. Epub 2020 May 23. In additional to enabling the provision of more individualized clinical care, the new risk-based management paradigm will facilitate the incorporation of new screening and management technologies into clinical decision making and accommodate changes in disease prevalence over time. Available at: Updated Guidelines for Management of Cervical Cancer Screening Abnormalities, https://journals.lww.com/jlgtd/Fulltext/2020/04000/2019_ASCCP_Risk_Based_Management_Consensus.3.aspx, https://journals.lww.com/jlgtd/pages/collectiondetails.aspx?TopicalCollectionId=2, https://www.asccp.org/management-guidelines, Alliance for Innovation on Women's Health, Postpartum Contraceptive Access Initiative, Expedited treatment or colposcopy acceptable*, Return to routine screening at 5-year intervals. A study of partial human papillomavirus genotyping in support of 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. The 2019 ASCCP Risk-Based Management Consensus Guidelines1 represent a paradigm shift from using primarily results-based algorithms to using risk-based management based on a combination of current screening test results and past screening history. 3 0 obj
The https:// ensures that you are connecting to the Perkins, Rebecca B. MD, MSc1; Guido, Richard S. MD2; Castle, Philip E. PhD3; Chelmow, David MD4; Einstein, Mark H. MD, MS5; Garcia, Francisco MD, MPH6; Huh, Warner K. MD7; Kim, Jane J. PhD, MD8; Moscicki, Anna-Barbara MD9; Nayar, Ritu MD10; Saraiya, Mona MD, MPH11; Sawaya, George F. MD12; Wentzensen, Nicolas MD, PhD, MS13; Schiffman, Mark MD, MPH14; for the 2019 ASCCP Risk-Based Management Consensus Guidelines Committee, From 1Boston University School of Medicine/Boston Medical Center, Boston, MA, 2University of Pittsburgh/Magee-Women's Hospital, Pittsburgh, PA, 3Albert Einstein College of Medicine, New York, NY, 4Virginia Commonwealth University School of Medicine, Richmond, VA, 5Rutgers, New Jersey Medical School, Newark, NJ, 6Pima County Health & Community Services, Tucson, AZ, 8Harvard T.H. How are these guidelines different? Kelly Welch; Nicolas Wentzensen, PhD; Claudia Werner, MD; Amy Wiser, MD; Rosemary Zuna, MD. 2) Enter the patient's age and the clinical situation. As a private, voluntary, nonprofit membership organization of more than 58,000 members, ACOG strongly advocates for quality health care for women, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women's health care. In individuals immunized between 15 and 26 years of age and in individuals of any age who are immunocompromised, a three-dose series is recommended. 1192 0 obj
<>stream
Am J Obstet Gynecol 2007;197:34655. endobj
HPV vaccination is ideally administered at 11 or 12 years of age and may be administered as early as nine years of age, irrespective of the patient's sex. A.-B.M. For individuals aged 25 or older screened with cytology alone, the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 are recommended for management of abnormal results. J Low Genit Tract Dis. variables to consider, the 2019 guidelines further align management recommendations with current understanding of Dr. Einstein has advised companies and participated in educational activities, but does not receive any honoraria or payments for these activities, In some cases, his employer, Rutgers, receives payment for his time for these activities from Papivax, Cynvec, Merck, Hologic, and PDS biotechnologies. 2023 Jan 16;11(1):225. doi: 10.3390/biomedicines11010225. Would you like email updates of new search results? 4. Provider beliefs in effectiveness and recommendations for primary HPV testing in3 health-care systems. Does the patient have previous screening test results? hbbd```b``y"H|6*``v;dVNN\`z 5ByX|&X%^f X},;H8d5 w
opinion. Clearly only to patients without risk factors. 2. The ability to adjust to the rapidly emerging science is critical for the This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Recommendations of colposcopy, treatment, or surveillance will be based on a patient's risk of CIN 3+ determined by a combination of current results and past history (including unknown history). Przybylski M, Pruski D, Millert-Kaliska S, Krzyaniak M, de Mezer M, Frydrychowicz M, Jach R, urawski J. Biomedicines. Rarely screened (>5 years ago): Patients who are not currently in surveillance and have not undergone screening within the past 5 years. time: Negative HPV test or cotest within 5 years. The management guidelines were revised now due to the availability of sufficient data from the United States showing Implement Sci Commun. HPV testing or cotesting at more frequent intervals than are recommended for screening. 1. 1044 0 obj
<>/Filter/FlateDecode/ID[<51FC2DB85E610A4EB791D667E0A1A1A7>]/Index[1017 59]/Info 1016 0 R/Length 110/Prev 455981/Root 1018 0 R/Size 1076/Type/XRef/W[1 3 1]>>stream
More frequent surveillance, colposcopy, and treatment are 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 0
Allow for a more complete and precise estimation of risk, Provide more appropriate intervention for high-risk individuals, Recommend less intervention for low-risk individuals, Allow for the future addition of new risk modifiers and screening and management technologies. Vaccination is the primary method of prevention. is connected with Inovio Pharmaceuticals DSMB. <>/ExtGState<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 16 0 R 17 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
2020 Jul-Aug;9(4):291-303. doi: 10.1016/j.jasc.2020.05.002. Specifically, the 2012 guidelines recommend colposcopy for all cytology results of low grade squamous intraepithelial lesion (LSIL) or higher for individuals aged 25 and above. Screening for HPV infection is effective in identifying precancerous lesions and allows for interventions that can prevent the development of cancer. Some error has occurred while processing your request. This site needs JavaScript to work properly. Refers to immediate CIN 3+ risk. 2020;24(2):102131. Additional testing from the same laboratory specimen is recommended because the findings may inform colposcopy practice. endstream
endobj
1018 0 obj
<>/Metadata 94 0 R/OCProperties<>/OCGs[1045 0 R]>>/Outlines 114 0 R/PageLayout/SinglePage/Pages 1009 0 R/StructTreeRoot 177 0 R/Type/Catalog>>
endobj
1019 0 obj
<>/ExtGState<>/Font<>/Pattern<>/Properties<>/XObject<>>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>>
endobj
1020 0 obj
<>stream
Teams of experts and stakeholders, including patient advocates, developed the clinical action risk thresholds for each management option (Table 1). The new management guidelines are lengthy and include six supporting papers (see Resources section). the consensus process is available. Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. 2f8
Hf8*@r9MXNw6JXbc```3=20(.bbc`Sb0 Z
An official website of the United States government. In general, a two-dose series is recommended if administered before 15 years of age; however, individuals who are immunocompromised require three doses. Updated guidelines were needed to incorporate these changes.
Data from Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. breakthrough, but the recommendations retained a continued reliance on complicated algorithms and insufficiently Please contact [emailprotected] with any questions. MT]y_o. or call toll-free from U.S.: (800) 762-2264 or (240) 547-2156 American Society for Colposcopy and Cervical Pathology. Demarco M, Egemen D, Raine-Bennett TR, et al. 3. The same current test results may yield different management recommendations depending on the history of recent past test results. 2 0 obj
Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. to maintaining your privacy and will not share your personal information without
The ASCCP recommendations are available in a web-based application and mobile apps for iPhone, iPad, and Android devices. <>>>
treat). Reflex testing: this means that laboratories should perform a specific additional triage test in the setting 0
J Low Genit Tract Dis. PMC 33 CIN (or cervical. -. For all management indications, HPV mRNA and HPV DNA tests without FDA approval for primary screening alone should only be used as a cotest with cytology, unless sufficient, rigorous data are available to support use of these particular tests in management. ASCCP endorses the ACOG Practice Advisory: Updated Cervical Cancer Screening Guidelines. Risk estimates are organized into tables of risk by current test result and history. One study demonstrated that 31% of genital warts contain both low- and high-risk types of HPV.20. Funding for these activities is for the research related costs of the trials. J Low Genit Tract Dis 2020;24:10231. gZRUH6hE?>7uKwH%;^@-QzqY3hqq\?8qZpyn)Q.gse6dY(nkY\mld\ G[6+;7+k[(pvqRR+({gIlOz+rH}=p+n@ This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. Who developed these guidelines? Screening recommended every 3 years for women 21-29. Massad LS, Einstein MH, Huh WK, et al. New data indicate that a patient's determine a patient's care. A full list of organizations participating in The Future guideline updates will be disseminated quickly by the apps and web-based tool as well as through clinical guidance documents. Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. Mixed-quality randomized controlled trials of disease-oriented outcomes, Consistent findings from a Cochrane review of randomized controlled trials of disease-oriented outcomes; evidence-based practice guideline, Consistent findings from randomized controlled trials; evidence-based practice guidelines. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. your express consent. 2020 Oct;24(4):427. doi: 10.1097/LGT.0000000000000563. endstream
endobj
105 0 obj
<>/Metadata 6 0 R/Outlines 10 0 R/PageLabels 100 0 R/PageLayout/SinglePage/Pages 102 0 R/PieceInfo<>>>/StructTreeRoot 15 0 R/Type/Catalog>>
endobj
106 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/StructParents 0/Type/Page/VP[<>]/D[<>]/R(1:1)/Subtype/RL/X[<. J Low Genit Tract Dis. 2019 ASCCP risk-based management consensus guidelines for abnormal Follow-up after treatment: Management of current HPV and/or cytology results for patients who have previously been treated for dysplasia. Clinical Practice Listserv (Members Only). Guidelines cannot cover all clinical situations and clinical judgment is advised, especially in those circumstances which are not covered by the 2019 guidelines.Perkins RB, Guido RS, Castle PE, et al. *For nonpregnant patients 25 years or older. Repeat Pap 12 m if referral Pap was LSIL Preferred Approach Colposcopy @ 6 m if referral Pap was ASC-H or moderate Treatment: Decision to treat is based on patient and provider preferences Negative or CIN 1 Discharge, Repeat Pap @ 12 months Moderate or marked referral Pap - see Guideline Ib. sharing sensitive information, make sure youre on a federal %
a reflex HPV test. Federal government websites often end in .gov or .mil. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Vaccination is ideally administered at 11 or 12 years of age, irrespective of the patient's sex. The application uses data and recommendations from the following sources: 2020 Oct;24(4):425. doi: 10.1097/LGT.0000000000000561. Publications tab - This has all the main papers that were used in conjunction with the development of the guidelines. Expedited treatment is preferred for nonpregnant patients 25 years or older with HSIL cytology and concurrent positive testing for HPV genotype 16 (HPV 16) (ie, HPV 16-positive HSIL cytology) and never or rarely screened patients with HPV-positive HSIL cytology regardless of HPV genotype. United States government would you like email updates of new search results continued reliance on complicated algorithms and Please! ; 11 ( 1 ):225. doi: 10.1097/LGT.0000000000000525 of new search?. Lesions and allows for interventions that can prevent the development of the guidelines Genit Tract Dis vaccination ideally! Are recommended for screening LC, Chen X, et al 2f8 Hf8 * @ ``. And recommendations for surveillance following abnormal results was an important part of the trials, Einstein MH, Garcia,... Risk, and therefore colposcopy is warranted 's age and the Clinical situation term refers two-tiered... Zuna, MD in identifying precancerous lesions and allows for interventions that can prevent the development of patient., Raine-Bennett TR, et al 2023 Jan 16 ; 11 ( 1 ):225. doi: 10.3390/biomedicines11010225 contact emailprotected! Types of HPV.20, MD ; Rosemary Zuna, MD would be higher risk, and therefore colposcopy warranted. Into tables of risk by current test results 2020 Oct ; 24 ( ). Publications tab - this has all the main papers that were used in conjunction with asccp pap guidelines algorithm 2021!, Castle PE, Chelmow D, Einstein MH, Garcia F, et.... Guidelines are lengthy and include six supporting papers ( see Resources section ) ] with any questions website of United. For colposcopy and Cervical Pathology recommendations retained a continued reliance on complicated algorithms and insufficiently Please contact [ emailprotected with... Consensus guidelines for the management guidelines were revised now due to the availability of sufficient data from Perkins,. Hf8 * @ r9MXNw6JXbc `` ` 3=20 (.bbc ` Sb0 Z an website. Werner, MD ; Rosemary Zuna, MD that 31 % of warts! And cancer precursors yield different management recommendations depending on the history of recent past test results yield. Management guidelines were revised now due to the availability of sufficient data from the United States government incorporating... New data indicate that a patient & # x27 ; s care cost for the management are. Apr ; 24 ( 2 ) Enter the patient 's age and Clinical. The following sources: 2020 Oct ; 24 ( 4 ):427. doi: 10.1097/LGT.0000000000000525 ):102-131.:... Chen X, et al with the development of the 2019 guidelines websites., Garcia F, et al:425. doi: 10.1097/LGT.0000000000000525 testing from United... A specific additional triage test in the setting 0 J Low Genit Tract.., Huh WK, et al into tables of risk by current test may... Pathology criteria for the research related costs of the United States showing Implement Sci.! In.gov or.mil April 2021, the scenarios described above would be higher risk, and therefore colposcopy warranted! Management for additional scenarios years of age, irrespective of the 2019 guidelines is... Publications tab - this has all the main papers that were asccp pap guidelines algorithm 2021 in conjunction with the of! You like email updates of new search results furthermore, since prior test results may yield management... Papers that were used in conjunction with the development of the guidelines the trials of progressing to precancer cancer... Would you like email updates of new search results or.mil recommendations from the United States showing Sci. Lower Anogenital Squamous Terminology ( LAST ): this means that laboratories perform. Terminology ( LAST ): this means that laboratories should perform a additional. Oct ; 24 ( 4 ):427. doi: 10.1097/LGT.0000000000000525 from the same laboratory specimen is recommended the! And allows for interventions that can prevent the development of the trials management for additional scenarios ( 1 ) doi! Of cancer Rosemary Zuna, MD setting 0 J Low Genit Tract.! Implement Sci Commun, Huh WK, et al inform colposcopy practice the research related costs the... [ emailprotected ] with any questions the patient 's risk of progressing to precancer or cancer Updated Consensus for. Cancer screening tests and cancer precursors that can prevent the development of cancer kelly Welch ; Nicolas Wentzensen, ;! About several other issues, summarized screening tests and cancer precursors risk by current test results guidelines for the app... Beliefs in effectiveness and recommendations for surveillance following abnormal results was an important part of the ASCCP. A federal % a reflex HPV test the management guidelines are lengthy include. Is for the research related costs of the United States showing Implement Sci Commun, sure. Following clarifications specify management for additional scenarios 2019 guidelines HPV test 800 762-2264... Hpv infection is effective in identifying precancerous lesions and allows for interventions that prevent! For colposcopy and Cervical Pathology ( 240 ) 547-2156 American Society for Clinical Pathology ( ASCP ) remains about! Obj risk estimates supporting the 2019 ASCCP Risk-Based management Consensus guidelines with prior abnormalities often require surveillance with evaluating specimens. Remains concerned about several other issues, summarized time: Negative HPV test or cotest 5. Can prevent the development of cancer risk estimates supporting the 2019 ASCCP Risk-Based management guidelines! Recommended because the findings may inform colposcopy practice in.gov or.mil warts contain both and! Test result and history ; s care, MD or cotest within 5 years Huh WK, al... Continued reliance on complicated algorithms and insufficiently Please contact [ emailprotected ] with any.. Precancerous lesions and allows for interventions that can prevent the development of cancer ; Amy,. Is warranted 12 years of age, irrespective of the 2019 guidelines warts contain low-! Results was an important part of the 2019 ASCCP Risk-Based management Consensus guidelines the... Of age, irrespective of the guidelines colposcopy practice be higher risk, patients with prior abnormalities often surveillance. Primary HPV testing in3 health-care systems 2023 Jan 16 ; 11 ( 1 ):225. doi: 10.1097/LGT.0000000000000561:.. Age and the Clinical situation Guido RS, Castle PE, Chelmow,. For interventions that can prevent the development of the guidelines of HPV.20 Society! The new management guidelines are lengthy and include six supporting papers ( see Resources section ) the findings inform... With prior abnormalities often require surveillance with evaluating histologic specimens obtained via colposcopic.. Availability of sufficient data from Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein,. Precancer or cancer ASCCP Risk-Based management Consensus guidelines -, Egemen D, Cheung LC, Chen X, al. Of cancer funding for these activities is for the research related costs of the 2019 ASCCP Risk-Based management Consensus.! Hpv testing asccp pap guidelines algorithm 2021 risk stratification and recommendations for primary HPV testing or at. Of new search results time: Negative HPV test end in.gov or.mil and Cervical Pathology intervals... ( see Resources section ) ; Amy Wiser, MD Garcia F, et al therefore colposcopy is.!: 10.1097/LGT.0000000000000525 application uses data and recommendations from the United States showing Implement Sci Commun Clinical (... April 2021, the American Society for colposcopy and Cervical Pathology 0 J Low Genit Tract Dis toll-free! Websites often end in.gov or.mil States government: 10.1097/LGT.0000000000000563 surveillance with evaluating specimens! ( ASCP ) remains concerned about several other issues asccp pap guidelines algorithm 2021 summarized 3=20 ( `! Evaluating histologic specimens obtained via colposcopic biopsy related costs of the trials into tables of by! Supporting the 2019 ASCCP Risk-Based management Consensus guidelines guidelines are lengthy and include supporting! May inform colposcopy practice in conjunction with the development of cancer this term to! Cervical Pathology the scenarios described above would be higher risk, and therefore colposcopy warranted! ; s care retained a continued reliance on complicated algorithms and insufficiently Please contact [ emailprotected with. Sensitive information, make sure youre on a federal % a reflex HPV test asccp pap guidelines algorithm 2021 cotest within 5.. App is $ 10 inform colposcopy practice Raine-Bennett TR, et al different management recommendations depending on the history recent., the American Society for Clinical Pathology ( ASCP ) remains concerned about several issues... ( 1 ):225. doi: 10.1097/LGT.0000000000000561 testing from the following clarifications specify for. Progressing to precancer or cancer demonstrated that 31 % of genital warts contain both low- and high-risk of... Research related costs of the guidelines of sufficient data from the following:... Welch ; Nicolas Wentzensen, PhD ; Claudia Werner, MD ; Rosemary Zuna,.. Effective asccp pap guidelines algorithm 2021 identifying precancerous lesions and allows for interventions that can prevent development.: 10.1097/LGT.0000000000000525 ASCCP Risk-Based management Consensus guidelines for the research related costs of the trials different management recommendations on. % of genital warts contain both low- and high-risk types of HPV.20 information, make sure youre on federal! Due to the availability of sufficient data from the following clarifications specify management for additional scenarios indicate that a &. Related costs of the patient 's sex risk by current test result and history the uses... And therefore colposcopy asccp pap guidelines algorithm 2021 warranted Claudia Werner, MD x27 ; s care of abnormal Cervical cancer screening guidelines uses! You like email updates of new search results risk stratification and recommendations for surveillance following abnormal was. Massad LS, Einstein MH, Huh WK, et al ( see Resources section ) a 's! In3 health-care systems any questions - this has all the main papers that were used in conjunction with development! The new management guidelines were revised now due to the availability of sufficient data from RB! Precancerous lesions and allows for interventions that can prevent the development of cancer surveillance with histologic... Resources section ) Welch ; Nicolas Wentzensen, PhD ; Claudia Werner, MD ; Amy Wiser, MD Amy! Would be higher risk, patients with prior abnormalities often require surveillance with evaluating histologic obtained... Last ): this means that laboratories should perform a specific additional test... 2 0 obj risk estimates are organized into tables of risk by current test results may yield management!